Clinical course and significance of hypertrophic cardiomyopathy without left ventricular hypertrophy

Back

ESC Premium Access

Clinical course and significance of hypertrophic cardiomyopathy without left ventricular hypertrophy

Session: Cardiac phenotyping and outcome implications

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor N. Maurizi (Lausanne, CH)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Niccolo' Maurizi

University Hospital of Lausanne, Lausanne (Switzerland)

4 presentations

0 follower

6 more presentations in this session

Short-term adverse remodelling in asymptomatic aortic stenosis: a longitudinal cardiovascular magnetic resonance imaging study

Speaker: Doctor A. Singh (Leicester, GB)

Insulin resistance, left ventricular hypertrophy and the impact of metformin use on cardiovascular outcomes in patients with calcific aortic stenosis: a genetic and population cohort study

Speaker: Doctor I. Mordi (Dundee, GB)

Prognostic value of cardiac damage in patients with symptomatic severe aortic stenosis: implementation of a newly proposed staging classification

Speaker: Mrs E. Vollema (Leiden, NL)

Trends in prevented sudden death in cardiomyopathies and channelopathies

Speaker: Doctor J. Gimeno Blanes (Murcia, ES)

Prognostic value of progressive decrease in left ventricular wall thickness for the evaluation of sudden cardiac death risk in patients with hypertrophic cardiomyopathy.

Speaker: Doctor A. Quiroga (Buenos Aires, AR)

Access the full session

Cardiac phenotyping and outcome implications

Speakers: Doctor N. Maurizi, Doctor A. Singh, Doctor I. Mordi, Mrs E. Vollema, Doctor J. Gimeno Blanes...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources